IFN-α
Showing 1 - 25 of 2,375
Myeloid Leukemia, MDS Trial (IFN-?)
Not yet recruiting
- Myeloid Leukemia
- Myelodysplastic Syndromes
- (no location specified)
Nov 15, 2023
Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)
Recruiting
- Hepatitis B, Chronic
- PEGylated recombinant human interferon alpha-2b injection
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of Anhui Medical University
Jun 24, 2023
Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)
Not yet recruiting
- Chronic Hepatitis B
- PEG IFN α-2b; TAF
- (no location specified)
Aug 5, 2022
Gene Expression Of Suppressor Of Cytokines in In Cutaneous Warts
Not yet recruiting
- Warts
- Detection of expression of SOCS3 gene
- +2 more
- (no location specified)
Mar 12, 2023
Melanoma Trial in Xi'an (Recombinant human interferon a1b, Toripalimab, Anlotinib HCl)
Not yet recruiting
- Melanoma
- Recombinant human interferon α1b
- +2 more
-
Xi'an, Shaanxi, ChinaAir Force Military Medical University/ Fourth Military Medical U
Sep 13, 2022
Hepatitis B, Chronic Trial in Guangzhou (ASC42 10mg, ASC42 15mg, ih PEG-IFN a-2a)
Recruiting
- Hepatitis B, Chronic
- ASC42 10mg
- +4 more
-
Guangzhou, Guangdong, ChinaNanFang Hospital of Southern Medical University
Jan 13, 2022
Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)
Recruiting
- Adult T-cell Leukemia-Lymphoma
- ATLL
- Belinostat
- +3 more
-
Miami, FloridaUniversity of Miami
Jan 24, 2022
Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +2 more
- Cemiplimab-Rwlc
- PEG-IFN alfa-2a
-
Miami, FloridaMiami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023
COVID-19, Children Trial in Shanghai (Inhaled Interferon a2b, Standard of Care)
Recruiting
- COVID-19
- Children
- Inhaled Interferon α2b
- Standard of Care
-
Shanghai, ChinaChildren Hospital of Fudan University
May 18, 2022
Chronic HBV Infection Trial in China (Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs), HH-003 and NrtIs, HH-003,
Recruiting
- Chronic HBV Infection
- Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
- +2 more
-
Beijing, Beijing, China
- +7 more
Feb 23, 2023
Acute Myeloid Leukemia Trial in Ann Arbor (peg-IFN-a, Hematopoietic Cell Transplant (HCT), Tacrolimus)
Completed
- Acute Myeloid Leukemia
- peg-IFN-α
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Oct 1, 2021
B-cell Acute Lymphoblastic Leukemia Trial in Suzhou (IFN-a combined with CAR-T cell therapy)
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- IFN-α combined with CAR-T cell therapy
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Aug 28, 2020
HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)
Unknown status
- HIV
- +2 more
- Pegylated Interferon alpha 2b (peg-IFN-α2b)
- 3BNC117 + 10-1074
-
Philadelphia, Pennsylvania
- +1 more
Jun 22, 2021
HBeAg Positive Chronic Hepatitis B Trial in Beijing (NAs+IFN-a)
Not yet recruiting
- HBeAg Positive Chronic Hepatitis B
-
Beijing, Beijing, ChinaMin Zhang
Sep 28, 2020
Hepatitis B, Chronic Trial in Worldwide (BRII-835 (VIR-2218), BRII-179 (VBI-2601) with IFN-a, BRII-179 (VBI-2601))
Active, not recruiting
- Hepatitis B, Chronic
- BRII-835 (VIR-2218)
- +2 more
-
Kingswood, New South Wales, Australia
- +27 more
Mar 1, 2022
Leukemia Trial in Philadelphia (Interferon alpha-2B (IFN-a) 3 million units (MU) subcutaneous daily)
Completed
- Leukemia
- Interferon alpha-2B (IFN-α) 3 million units (MU) subcutaneous daily
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Apr 20, 2020
Malignant Tumor of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial
Completed
- Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface
- +2 more
- DC vaccine
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 6, 2020
Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma
Recruiting
- Stage III Hepatocellular Carcinoma AJCC v8
- +6 more
- Fluorouracil
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 18, 2021
COVID-19, Recombinant Human Interferon a1ß Trial (Recombinant human interferon a1ß)
Unknown status
- COVID-19
- Recombinant Human Interferon α1β
- Recombinant human interferon α1β
- (no location specified)
Mar 2, 2020
Type I IFN Level and Disease Activity in SLE Patients
Not yet recruiting
- Elevated Level of IFN Type I in SLE Patients
- study of IFNGS expression biomarkers
- (no location specified)
Jun 30, 2022
Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant
Not yet recruiting
- Breast Cancer Triple Negative
- +3 more
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
May 18, 2023
Asthma in Children, Atopy, Viral Upper Respiratory Infection Trial in Washington (Omalizumab, Placebo)
Recruiting
- Asthma in Children
- +2 more
- Omalizumab
- Placebo
-
Washington, District of ColumbiaChildren's National Hospital
Aug 26, 2022
Liver Metastasis Colon Cancer Trial (IRE plus checkpoint inhibitor, IRE plus Checkpoint Inhibitor plus CpG-ODN)
Not yet recruiting
- Liver Metastasis Colon Cancer
- IRE plus checkpoint inhibitor
- IRE plus Checkpoint Inhibitor plus CpG-ODN
- (no location specified)
Sep 13, 2023
Rheumatoid Arthritis Trial (probiotic therapy)
Not yet recruiting
- Rheumatoid Arthritis
- probiotic therapy
- (no location specified)
Mar 8, 2023
Cancer, Treatment-Related, Tumor of Breast, Systemic Inflammatory Response Trial in Roma (cryoablation)
Completed
- Cancer, Treatment-Related
- +3 more
- cryoablation
-
Roma, ItalySapienza University of Rome
Feb 13, 2023